Corticosteroid Injection Addition to Casting is Superior to Casting Alone for De Quervain's Disease .
Methylprednisolone acetate injection with casting versus casting alone for the treatment of De-Quervain's Tenosynovitis: a randomized controlled trial.
J Pak Med Assoc. 2020 Aug;70(8):1314-1318.One hundred and seventy-four patients with De Quervain's tenosynovitis were randomized to receive a thumb Spica cast and a corticosteroid injection (1mL of 10 mg) of triamcinolone acetonide and (1mL) lidocaine, or a thumb Spica cast alone to evaluate improvement in pain and function. The primary outcomes of interest included pain on a Visual Analog Scale (VAS) and the Quick Disability of the Arm, Shoulder and Hand (QuickDASH) score. Both groups displayed significant improvements in VAS pain scores and QuickDASH scores after treatment compared to baseline scores. Between-group comparisons were not performed; however, the casting plus corticosteroid group demonstrated lower and thus, better VAS pain scores and QuickDASH scores compared to the casting only group. A larger number of patients in the casting only group reported continuous pain following treatment compared to the casting plus corticosteroid group.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics